• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Change and Constancy: The 2025 CLFS Update

Change and Constancy: The 2025 CLFS Update

by Michael Schubert, PhD | Jan 21, 2025 | CMS-lca, Essential, Fee Schedules-lir, Funding-lir, Lab Industry Advisor, Reimbursement-lir

The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A Primer on PAMA

A Primer on PAMA

by Michael Schubert, PhD | Mar 27, 2024 | CMS-lca, Essential, Lab Industry Advisor, Legislation-lir, PAMA-lir, Reimbursement-lca

The impending legislation that may determine Medicare lab fees from 2025 onward

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Expert Q&A: What’s New with PAMA and SALSA?

Expert Q&A: What’s New with PAMA and SALSA?

by Rachel Muenz | Mar 25, 2024 | Essential, Lab Industry Advisor, Legislation-lca, PAMA-lir

Joyce Gresko, partner at Alston & Bird, discusses the latest on PAMA and what will likely need to happen for SALSA to pass in 2024.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Comprehensive Coding

Comprehensive Coding

by Michael Schubert, PhD | Jan 23, 2024 | Essential, Fee Schedules-lir, Lab Industry Advisor, Reimbursement-lir

Understanding the 2024 CLFS update—and the changes that are still to come.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Reproposed SALSA Offers Real Chance of Long-Term PAMA Relief

Reproposed SALSA Offers Real Chance of Long-Term PAMA Relief

by Glenn S. Demby | Jun 28, 2023 | Essential, Legislation-nir, National Lab Reporter

After it failed to pass at the end of 2022, lab leaders and other insiders say they’re optimistic SALSA will pass this year.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com